Entera Bio Ltd.

NASDAQ:ENTX

1.98 (USD) • At close September 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 00.0420.0820.0420.05704.4820000.0140.0080.0440.0680.1650.140.1090.1570.2210.050.0520.0420.1020.060.07400.500000000000
Cost of Revenue 0.0070.0420.0820.0420.0480.0130.0130.0140.0152.2120.0080.0060.0330.0540.1870.0650.0630.0730.1050.0310.0310.0420.1080.040.0620000000000000
Gross Profit -0.0070000.009-0.0134.469-0.014-0.015-2.2120.0060.0020.0110.014-0.0220.0750.0460.0840.1160.0190.0210-0.0060.020.01200.500000000000
Gross Profit Ratio 00000.15800.9970000.4290.250.250.206-0.1330.5360.4220.5350.5250.380.4040-0.0590.3330.1620100000000000
Reseach & Development Expenses 1.521.1231.2011.4771.0860.7220.9871.371.2090.9311.3511.4131.3941.692.6251.7291.2581.1241.1761.6062.0111.6051.9651.7861.4132.0352.0541.8061.7652.8931.0820.4060.6010.640.7970.9270.5210.462
General & Administrative Expenses 1.1481.441.1361.5441.0881.3270.9731.0281.1351.2941.7411.461.882.1711.4811.451.451.3091.2350.8291.5371.291.5241.0730.6281.0560.9291.06-0.4091.2633.3082.3732.3921.4470.4230.5071.2270.895
Selling & Marketing Expenses 00000000000000000000000000000000000000
SG&A 1.1481.441.1361.5441.0881.3270.9731.0281.1351.2941.7411.461.882.1711.4811.451.451.3091.2350.8291.5371.291.5241.0730.6281.0560.9291.06-0.4091.2633.3082.3732.3921.4470.4230.5071.2270.895
Other Expenses 000000000-0.013-0.018-0.0060-0.0120.023000000000000000.0200000000
Operating Expenses 2.6682.5632.3373.0212.1742.0491.962.3862.332.2123.0742.8673.263.8494.0933.1682.6962.4232.4112.4353.5482.8953.4892.8592.0413.0912.9832.8661.3564.1564.392.7792.9931.8481.221.4341.7480.698
Operating Income -2.6682.563-2.337-3.021-2.165-2.062-1.973-2.386-2.332.212-3.068-2.865-3.249-3.835-4.115-3.093-2.65-2.339-2.295-2.416-3.527-2.895-3.495-2.839-2.029-3.091-2.483-2.866-1.356-4.15618.296-2.779-2.993-2.087-1.22-1.434-1.748-1.357
Operating Income Ratio 061.024-28.5-71.929-37.9820-0.44000-219.143-358.125-73.841-56.397-24.939-22.093-24.312-14.898-10.385-48.32-67.827-68.929-34.265-47.317-27.4190-4.96600000000000
Total Other Income Expenses Net 0.012-0.004-0.00700.020.045-0.0320.0360.0050.022-0.013-0.0080.0740.0448.849-0.12-0.0240.0290.0640.7920.337-0.0230.055-0.1550.6630.096-0.162-2.22.91900.615-0.8770.7340.2040.363-0.304-0.2862.055
Income Before Tax -2.6562.567-2.344-3.021-2.145-2.017-1.995-2.35-2.325-2.19-2.889-2.857-3.189-3.7914.734-2.416-5.114-2.31-2.231-1.624-3.19-2.918-3.44-2.994-1.366-2.995-2.645-5.0661.563-4.156-3.775-3.656-2.259-1.883-0.857-1.738-2.0340.698
Income Before Tax Ratio 061.119-28.585-71.929-37.6320-0.445000-206.357-357.125-72.477-55.7528.691-17.257-46.917-14.713-10.095-32.48-61.346-69.476-33.725-49.9-18.4590-5.2900000000000
Income Tax Expense 000.014-6.0420000.0290-4.4150.32-0.194-0.004-0.007-0.1820.0450.04-0.0140.070.0130.029-0.0230.016000.01600.02300.02-22.6860-0.02000-0.020
Net Income -2.6562.567-2.358-3.021-2.145-2.017-1.995-2.379-2.3252.225-3.209-2.663-3.185-3.7844.916-2.461-5.154-2.296-2.251-1.624-3.19-2.918-3.44-2.994-1.366-2.995-2.645-5.0661.563-4.156-3.775-3.656-2.259-1.883-0.857-1.738-2.0340.698
Net Income Ratio 061.119-28.756-71.929-37.6320-0.445000-229.214-332.875-72.386-55.64729.794-17.579-47.284-14.624-10.186-32.48-61.346-69.476-33.725-49.9-18.4590-5.2900000000000
EPS -0.0570.06-0.0630.08-0.058-0.055-0.067-0.083-0.0810.077-0.11-0.092-0.11-0.131.02-0.086-0.21-0.1-0.12-0.09-0.17-0.16-0.29-0.25-0.12-0.26-0.23-0.450.35-0.36-0.32-0.43-0.26-0.22-0.1-0.2-0.240.25
EPS Diluted -0.0570.06-0.0630.08-0.058-0.055-0.067-0.083-0.0810.077-0.11-0.092-0.11-0.131.02-0.086-0.21-0.1-0.12-0.089-0.17-0.16-0.29-0.25-0.12-0.26-0.23-0.45-0.11-0.36-0.32-0.31-0.19-0.16-0.1-0.15-0.170.15
EBITDA -2.661-2.559-2.326-3.01-2.154-2.049-1.95-2.372-2.315-2.198-3.052-2.849-3.263-3.8194.734-3.205-2.555-2.33-2.108-2.365-3.476-2.845-3.371-2.776-1.963-3.035-2.466-2.856-1.349-4.136-4.378-2.767-2.993-2.078-1.211-1.425-1.748-1.348
EBITDA Ratio 0-60.929-28.366-71.667-37.7890-0.435000-218-356.125-74.159-56.16228.691-22.893-23.44-14.841-9.538-47.3-66.846-67.738-33.049-46.267-26.5270-4.93200000000000